Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome

DBCAT003826Pharmacologic class

Source: Volpi-abadie J, Kaye AM, Kaye AD. Serotonin syndrome. Ochsner J. A DrugBank category of 248 drugs. 185 of them are approved.

Also known as: Serotonin Syndrome
Drugs: 2,5-Dimethoxy-4-ethylamphetamine
2,5-Dimethoxy-4-ethylthioamphetamine
5-methoxy-N,N-dimethyltryptamine
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline
Alaproclate
Alfentanil
Almotriptan
Alphacetylmethadol
Alphaprodine
Amantadine
Amineptine
Amitriptyline
Amitriptylinoxide
Amoxapine
Amphetamine
Apomorphine
Aripiprazole
Aripiprazole lauroxil
Asenapine
Benmoxin
Benzphetamine
Bezitramide
Bifemelane
Blonanserin
Brexpiprazole
and 223 more with a free account

What you can answer from here — as of August 13, 2018

248DrugsEach linked to its full drug card

220Drug targetsEvery drug–target pair in the class, with bond type

77,286Marketed productsAcross the regions we cover, with dosage forms and routes

41Routes of administrationHow the drugs in this class are given

Which targets do Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.